-
EP0425909
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0425909
| EP0425909 - Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.04.1995 Database last updated on 12.11.2024 | Most recent event Tooltip | 19.06.1998 | Correction of patent application | published on 05.08.1998 [1998/32] | Applicant(s) | For all designated states E.R. Squibb & Sons, Inc. P.O.Box 4000 Princeton New Jersey 08543-4000 / US | [N/P] |
| Former [1991/19] | For all designated states E.R. SQUIBB & SONS, INC. P.O.Box 4000 Princeton New Jersey 08543-4000 / US | Inventor(s) | 01 /
Aberg, Gunnar A. K. 519 Bergen Street Lawrenceville, NJ 08648 / US | 02 /
Ondetti, Miguel A. 79 Hemlock Circle Princeton, NJ 08540 / US | [1991/19] | Representative(s) | Josif, Albert, et al Baaderstrasse 3 80469 München / DE | [N/P] |
| Former [1991/19] | Josif, Albert, Dr.-Ing., et al Baaderstrasse 3 D-80469 München / DE | Application number, filing date | 90119984.4 | 18.10.1990 | [1991/19] | Priority number, date | US19890426138 | 23.10.1989 Original published format: US 426138 | [1991/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0425909 | Date: | 08.05.1991 | Language: | EN | [1991/19] | Type: | A3 Search report | No.: | EP0425909 | Date: | 17.06.1992 | Language: | EN | [1992/25] | Type: | A3 RE Reissue of A-publication | No.: | EP0425909 | Date: | 05.08.1998 | [1998/32] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.04.1992 | Classification | IPC: | A61K31/40, A61K31/675, A61K37/64 | [1992/25] | CPC: |
A61K31/675 (EP,US);
A61K31/00 (EP,US);
A61K31/02 (EP,US);
A61K31/40 (EP,US);
A61K31/55 (EP,US);
A61K31/64 (EP,US);
|
| Former IPC [1991/19] | A61K31/40, A61K31/55, A61K31/675, A61K37/64 | Designated contracting states | DE, FR, GB, IT [1991/19] | Title | German: | Verfahren zur Rehabilisierung der durch beeinträchtigten Atherosklerose oder Hypercholesterolämie vasorelaxierenden Wirkung der Kranzarterien, unter Verwendung eines ACE-Inhibitors | [1991/19] | English: | Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor | [1991/19] | French: | Méthode pour restaurer l'activité vasorelaxante des artères coronaires, amoindrie par l'athérosclérose ou l'hypercholestérolémie, en utilisant un inhibiteur de l'ACE | [1991/19] | File destroyed: | 03.03.2001 | Examination procedure | 07.12.1992 | Examination requested [1993/05] | 13.05.1994 | Despatch of a communication from the examining division (Time limit: M06) | 24.11.1994 | Application deemed to be withdrawn, date of legal effect [1995/24] | 17.01.1995 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1995/24] | Fees paid | Renewal fee | 20.10.1992 | Renewal fee patent year 03 | 16.10.1993 | Renewal fee patent year 04 | 08.10.1994 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]EP0219782 (HOECHST AG [DE]); | [XP]EP0363671 (HOFFMANN LA ROCHE [CH]); | [E]EP0425956 (SQUIBB & SONS INC [US]); | [E]EP0426066 (SQUIBB & SONS INC [US]); | [E]EP0411395 (THERA PATENT VERWALTUNGS GMBH [DE]) | [X] - DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, vol. 113, no. 8, 26th February 1988, pages 300-302, DE; N. RIETBROCK et al.: "Antiischämische Wirksamkeit von Enalapril bei koronarer Herzkrankheit" | [X] - BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. 28, suppl. 2, 13th October 1989, pages 151S-157S; P.J. SHULTZ et al.: "Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations" | [X] - AMERICAN JOURNAL OF PHYSIOLOGY, vol. 257, no. 4, part 2 of two parts, October 1989, pages H1315-H1320, US; J.L. MEHTA et al.: "Modulation of vascular tone by neutrophils: dependence on endothelial integrity" | [X] - NICHIDAI IGAKU ZASSHI, vol. 43, no. 11, 1984, pages 897-906, JP; T. OSADA: "Effects of diltiazem and captopril on blood pressure, humoral factors and the vascular system in spontaneously hypertensive rats" | [X] - CLINICAL CARDIOLOGY, vol. 11, no. 4, April 1988, pages 246-249; C. STROZZI et al.: "Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina" | [X] - JOURNAL OF HYPERTENSION SUPPLEMENT, vol. 3, suppl. 2, November 1985, pages 147-148; C. STROZZI et al.: "Ergometric evaluation of the effects of captopril in hypertensive patients with stable angina" | [X] - AMERICAN HEART JOURNAL, vol. 101, no. 1, January 1981, pages 22-31, US; N.A. AWAN et al.: "Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure" | [X] - AMERICAN JOURNAL OF HYPERTENSION, vol. 1, no. 3, part 3, July 1988, pages 221S-223S, US; F.V. COSTA et al.: "Use of captopril to reduce serum lipids in hypertensive patients with hyperlipidemia" | [X] - THE TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, vol. 143, no. 1, May 1984, pages 127-128, JP; K. MIZUNO et al.: "Acute effect of captopril on serum lipid peroxides level in hypertensive patients" |